Patents by Inventor Ian Pryme

Ian Pryme has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein expression system
    Patent number: 9115364
    Abstract: The present invention relates to a method of producing a target protein, which method comprises expressing said protein in a host cell which contains a nucleic acid molecule which encodes a chimeric protein, said chimeric protein comprising a signal peptide from a non-mammalian bulk-secreted protein and said target protein; nucleic acids, vectors, host cells and kits for carrying out the method are also described.
    Type: Grant
    Filed: November 28, 2011
    Date of Patent: August 25, 2015
    Assignee: PROLUME LTD.
    Inventors: John Hesketh, Hanne Ravneberg, Christine Gjerdrum, Albert Tauler, Ian Pryme, Beate Stern
  • Protein Expression System
    Publication number: 20120142090
    Abstract: The present invention relates to a method of producing a target protein, which method comprises expressing said protein in a host cell which contains a nucleic acid molecule which encodes a chimeric protein, said chimeric protein comprising a signal peptide from a non-mammalian bulk-secreted protein and said target protein; nucleic acids, vectors, host cells and kits for carrying out the method are also described.
    Type: Application
    Filed: November 28, 2011
    Publication date: June 7, 2012
    Inventors: John Hesketh, Hanne Ravneberg, Christine Gjerdrum, Albert Tauler, Ian Pryme, Beate Stern
  • Protein expression system
    Patent number: 8067198
    Abstract: The present invention relates to a method of producing a target protein, which method comprises expressing said protein in a host cell which contains a nucleic acid molecule which encodes a chimeric protein, said chimeric protein comprising a signal peptide from a non-mammalian bulk-secreted protein and said target protein; nucleic acids, vectors, host cells and kits for carrying out the method are also described.
    Type: Grant
    Filed: June 25, 2004
    Date of Patent: November 29, 2011
    Assignee: Prolume Ltd.
    Inventors: John Hesketh, Hanne Ravneberg, Christine Gjerdrum, Albert Tauler, Ian Pryme, Beate Stern
  • Orally ingestible preparation of mistletoe lectins and method
    Patent number: 7550159
    Abstract: An orally ingestible preparation consisting essentially of Mistletoe lectin I (ML-I), Mistletoe lectin II (ML-II), and Mistletoe lectin III (ML-III), which specifically excludes the nausea-inducing compounds present in mistletoe extracts. The invention also provides for a method of producing said preparation, a method of using said preparation to produce pharmaceutical preparations, and a method for using said preparation in the treatment of patients suffering from cancer and auto immune diseases.
    Type: Grant
    Filed: November 12, 2001
    Date of Patent: June 23, 2009
    Assignee: Palm Research AS
    Inventor: Ian Pryme
  • Orally ingestible preparation of mistletoe lectins and method
    Publication number: 20040052869
    Abstract: An orally ingestible preparation consisting essentially of Mistletoe lectin I (ML-I), Mistletoe lectin II (ML-II), and Mistletoe lectin III (ML-III), which specifically excludes the nausea-inducing compounds present in mistletoe extracts. The invention also provides for a method of producing said preparation, a method of using said preparation to produce pharmaceutical preparations, and a method for using said preparation in the treatment of patients suffering from cancer and auto immune diseases.
    Type: Application
    Filed: September 22, 2003
    Publication date: March 18, 2004
    Inventor: Ian Pryme